Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis

International Journal of Tissue Reactions

Volumn 23, Issue 1, 2001, Pages 21-31

  Cavaletti, Guido ^a   Perseghin, P ^a   Buscemi, F ^a   Dassi, M ^a   Oggioni, N ^b   Sala, F ^b   Lolli, F ^c   Liuzzi, G M ^d   Riccio, P ^e   Frattola, L ^a,g   Tredici, G ^f  

^a SAN GERARDO HOSPITAL   (Italy)

^b Novuspharma SpA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e UNIVERSITY OF BASILICATA   (Italy)

^f UNIVERSITY OF MILANO BICOCCA   (Italy)

^g IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXSALEN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EXTRACORPOREAL CIRCULATION; FEMALE; FLOW CYTOMETRY; IMMUNOMODULATION; LYMPHOCYTE COUNT; MULTIPLE SCLEROSIS; NONHUMAN; PHOTOCHEMOTHERAPY; RAT; RAT STRAIN; ULTRAVIOLET A RADIATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; LYMPHOCYTE COUNT; METHOXSALEN; PHOTOPHERESIS; RATS; RATS, INBRED LEW; TREATMENT OUTCOME;

ANIMALIA;

EID: 0035012291     PISSN: 02500868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. McFarlin D.E., McFarland H.F. Multiple sclerosis. Part 1. N. Engl. J. Med, 307, 1183, 1982.
2. McFarlin D.E., McFarland, H.F. Multiple sclerosis. Part 2. N. Engl. J. Med., 307, 1246, 1982.
3. Hintzen R., Polman C.H., Lucas C.J., van Lier R.A.W. Multiple sclerosis: Immunological findings and possible implications for therapy. J. Neuroimmunol., 39, 1, 1992.
4. Martin R., Calabresi P., McFarland H.F. Experimental immunotherapies of multiple sclerosis. In: Zhang J., Hafler D., Hohfeld R., Miller A. (Eds.), "Immunotherapy in Neuroimmunological Diseases." Martin Dunitz, London, 1998, pp 29-73.
5. Martin R., McFarland H.F. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci., 32, 121, 1995.
6. Sorensen T.L., Tani M., Jensen J., et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest., 103, 807, 1999.
7. Karussis D.M., Abramsky O. Antigen nonspecific immunotherapy for multiple sclerosis and other neuroimmunologic diseases. In: Zhang J., Hafler D., Hohfeld R., Miller A. (E:ds.). "Immunotherapy in Neuroimmunological Diseases." Martin Dunitz, London, 1998, pp. 297-317.
8. Rudik R.A., Cohen J.A., Weinstock-Guttman B., Kinkel R.P., Ranshoff P.M. Management of multiple sclerosis. N. Engl. J. Med., 337, 1604, 1997.
9. Fassas A., Annagnostopoulos D., Kazis A., et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: First results of a pilot study. Bone Marrow Transplant. 20, 631, 1997.
10. Burt R.K., Traynor A.E., Cohen B., et al. Tcell depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report of the first three patients. Bone Marrow Transplant, 21, 537, 1998.
11. Sullivan K.M., Furst D.E. The evolving role of blood and marrow transplantation for the treatment of autoimmune diseases. J. Reumatol. Suppl., 48, 1, 1997.
12. Aringer M., Graininger W.B., Smolen J.S., Keiner H.P., Steiner L.W. Photopheresis treatment enhances CD95 (fas) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosis. Br. J. Rheumatol., 36, 1276, 1997.
13. Yoo E.K., Rook A.H., Elenitsas R., Gasparro F.P., Vowels B.R. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: Relevance to mechanism of therapeutic action. J. Invest. Dermatol., 108, 235, 1996.
14. Enomoto D.N., Schellekens P.T., Yong S.L., Ten Berge I.J., Mekkes J.R. Extracorporeal photochemotherapy (photopheresis) induces apoptosis in lymphocytes: A possible mechanism of action Of PUVA therapy. Phothochem. Photobiol., 65, 177, 1997.
15. Vowels B.R., Cassin M., Boufal M.H., Walsh L.J., Rook A.H. Extracorporeal photochemotherapy inuces the production of tumor necrosis factor-α. by monocytes: Implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J. Invest. Dermatol., 98, 686, 1992.
16. Barr M.L, Meiser B.M., Eisen H.J., et al. Photopheresis in the prevention of rejection in cardiac transplantation. N. Engl. J. Med., 339, 1744, 1998.
17. Knobler R.M., Graininger W., Lindmaier A., Trautinger F., Smolen J. Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. Arthritis Rheum., 35, 319, 1992.
18. Costanzo-Nordin M.R., Hubbel E.A., O'Sullivan E.J., Robinson J.A. Successful treatment of heart transplantation rejection with photopheresis. Transplantation, 53, 808, 1992.
19. Edelson R.L., Heald P.W., Perez M.I., Berger C. Extracorporeal photochemotherapy. Biol. Ther. Cancer Updates, 4, 1, 1994.
20. Sunder-Plassmann G., Druml W., Steininger R., Honigsmann H., Knobler R. Renal allograft rejection controlled by photopheresis. Lancet. 364, 506, 1995.
21. Gerber M., Gmeinhart B., Volc-Platzer B., Kahls P., Greinix H., Knobler R. Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP). Bone Marrow Transplant, 19, 517, 1997.
22. Greinix H.T., Volc-Platzer B., Rabitsch W., et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood, 92, 3098, 1998.
23. Poehlau D., Rieks M., Posted T., et al. Photopheresis - A possible treatment of multiple sclerosis?: Report of two cases. J. Clin. Apher., 12, 154, 1997.
24. Rostami A.M., Sater R.A., Bird S.J., et al. A double-blind, placebo-controlled trial of extracorporeal photopheresis in chronic progressive multiple sclerosis. Mult. Scler., 5, 198, 1999.
25. Wekerle H., Kojima K., Lannes Vieira J., Lassmann H., Linington C. Animal models. Ann. Neurol., 36, 47, 1994,
26. Khavari P.A., Edelson R.L., Lider O., Gasparro F.P., Weiner H.L., Cohen I.R. Specific vaccination against photoinactivated cloned Tcells. Clin. Res., 36, 662, 1998.
27. Andreu G., Leon A., Heshmati F, Tod M., Menkes C.J. Extracorporeal photochemotherapy: Evaluation of two techniques and use in connective tissue disorders. Tranfus. Sci., 15, 443, 1994.
28. Perotti C., Torretta L., Viarengo G., Roveda L., Bernuzzi S. Feasibility and safety of a new technique of ECP: Experience of 240 procedures. Hematologica, 84, 237, 1999.
29. Andreu G., Boccaccio C., Klarem J., Lecrubier C.H., Pirenne F. The role of UV irradiation in the prevention of HLA alloimmunization. Transf. Med. Rev., 6, 212, 1992.
30. Birnbaum G., Kotilinek L., Miller S., Raine C.S., Gao Y.L. Heat shock proteins and experimental autoimmune encephalomyelitis II: Environmental infections and extra-neuraxial inflammation alter the course of chronic relapsing encephalomyelitis. J. Neuroimmunol., 90, 149, 1998.
31. Robinson, JP. "Handbook of Flow Cytometry Methods." Wiley-Liss, New York, 1993, pp. 70-72.
32. Ovens M.A., Loken, M.R. "Flow Cytometry Principles for Clinical Laboratory Practice." Wiley-Liss, New York, 1995, pp.175-184.
33. Lolli F., Liuzzi G.M., Vergelli M., Massacesi L., Ballerini C. Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis. J Neuroimmunol., 44, 69, 1993.
34. Vukmanovic S., Mostarica-Stojkovic M., Zalud I., Ramic Z., Lukic M.L. Analysis of cell subsets after induction of experimental autoimmune encephalomyelitis in susceptible and resistant strains of rats. J. Neuroimmunol., 27, 63, 1990.
35. Traugot U. Experimental allergic encephalomyelitis -Migration of early T cells from the circulation into the central nervous system. J. Neurol. Sci., 36, 55, 1978.
36. Lublin F.D., Tippet D.L., Maurer RH. Central nervous system and blood lymphocytes in experimental allergic encephalomyelitis. J. Clin. Lab. Immunol., 10, 139, 1983.
37. -1 cells in peripheral blood. J. Neuroimmunol., 133, 3037, 1984.
38. Van Lambalgen R., Jonker M. Experimental allergic encephlomyelitis in rhesus monkies. I. Immunological parameters in EAE resistant and susceptible rhesus monkies. Clin. Exp. Immunol., 68, 100, 1987.
39. Kaser A., Deisenhammer F., Berger T., Tilg H. Interferon-β1b augments activation-induced T-cell death in multiple sclerosis patients. Lancet, 353, 1413, 1999.
40. Fritz T.M., Kleinhans M., Nestle F.O., Burg G., Dummer R. Combination treatment with extracorporeal photopheresis, Interferon alfa and interleukin-2 in a patient with Sezary syndrome. Br. J. Dermatol., 140, 1144, 1999.
41. Yasumoto S., Moroi Y., Koga T., Kawamura I., Mitsuyama M., Hori Y. Ultraviolet-B irradiation alters cytokine production by immune lymphocytes in herpes simplex virus-infected mice. J. Dermatol. Sci., 8, 218, 1994.
42. Schmitt D.A., Owen-Schaub L., Ullrich S.E. Effect of IL-12 on immune suppression and suppressor cell induction by ultraviolet radiation. J. Immunol., 154, 5114, 1995.
43. Jones C.D., Guckian M., El-Ghorr A.A., Gibbs N.K., Norval M. Effects of phototherapy on the productionof cytokines by peripheral blood mononuclear cells and on systemic antibody responses in patients with psoriasis. Photodermatol. Photoimmunol. Photomed., 12, 204, 1996.
44. Argane Y., Schwarz A., Luger T.A., Ariizumi K., Takashima A., Schwarz T. Ultraviolet light suppresses IFN-gamma-induced IL-7 gene expression in murine keratinocytes by interfering with IFN regulatory factors. J. Immunol., 158, 5393, 1997.
45. El-Ghorr A.A., Norval M. The role of interleukin-4 in ultraviolet B light-induced immunosuppression. Immunol., 92, 26, 1997.
46. El-Ghorr A.A., Horsburg G., Norval M. The effect of UVB irradiation on antibody responses during herpes simplex virus type 1 (HSV-1) infection of mice. Photodermatol. Photoimmunol. Photomed., 14, 17, 1998.
47. Danno K., Kaji A., Mochizuki T. Alterations in ICAM-1 and ELAM-1 expression in psoriatic lesions following various treatments. J. Dermatol. Sci., 13, 49, 1996.
48. Perez M., Edelson R., Laroche L., Berger C. Inhibition of anti-skin allograft immunity by infusion with syngenic photoactivated effector lymphocytes. J. Invest. Dermatol., 92, 669, 1989.
49. Bisaccia E., Berger C., DiSpaltro F.X., Klainer A.S. Extracorporeal photopheresis in the treatment of AIDS-related complex: Extended trial. J. Acquir. Immune Defic. Syndr., 6, 386, 1993.
50. Biagi E., Perseghin P, Buscemi F., Dassi M., Rovelli A., Balduzzi A. Effectiveness of ECP in treating long-term refractory chronic GVHD. Haematologica, 85(3), 329, 2000.